Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy

Tanta University52 enrolled

Overview

Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy

Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Myopic Traction Maculopathy Pars Plana Vitrectomy Internal Limiting Membrane Peeling

Interventions

Pars Plana Vitrectomy with Internal Limiting Membrane peelPROCEDURE

Pars plana vitrectomy with staining and peeling of internal limiting membrane

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Highly myopic patients, having a refractive errors (spherical equivalent) of more than - 8 Diopter, or an axial length more than 26.5 mm. * Best Corrected Visual Acuity less than 0.1 * Spectral Domain Optical Coherence Tomography showed; staphylomatous changes, with either: Macular retinoschisis, foveal retinal detachment, full thickness macular hole (with or without macualr hole retinal detachment), or lamellar macular hole, with epiretinal membrane At least 6 months follow-up Exclusion Criteria: * Eyes with diffuse chorioretinal macular atrophy * Concomitant presence of a choroidal neovascular membrane * Young patients less than 21 years old. * History of trauma * Dense media opacity (corneal/ lenticular)

Outcomes

Primary Outcomes

Improvement of best corrected visual acuity

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.